May 7, 2026 07:00AM
Apr 28, 2026 05:06AM
Apr 27, 2026 02:55PM
Apr 27, 2026 01:56PM
Apr 27, 2026 07:01AM
Apr 27, 2026 07:00AM
Apr 27, 2026 07:00AM Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator 
Apr 27, 2026 07:00AM
Feb 26, 2026 07:00AM
Dec 9, 2025 04:23PM
Nov 7, 2025 08:01AM
Nov 6, 2025 07:00AM
Aug 7, 2025 02:35PM
Aug 7, 2025 07:00AM Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
Jul 30, 2025 06:32AM
Jul 17, 2025 07:34AM
Jul 10, 2025 08:02AM
Jul 10, 2025 08:00AM
Jul 2, 2025 07:01AM
Jul 2, 2025 07:00AM
Jul 2, 2025 07:00AM Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
May 8, 2025 07:00AM
Apr 17, 2025 06:00AM
Feb 27, 2025 07:00AM
Dec 10, 2024 09:15AM
Dec 10, 2024 09:00AM
Nov 7, 2024 07:00AM
Oct 17, 2024 07:30AM Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Aug 6, 2024 04:01PM
Jul 24, 2024 06:33AM
Jul 24, 2024 06:30AM
Jul 8, 2024 07:03AM
Jul 8, 2024 07:00AM
May 7, 2024 04:00PM
Feb 27, 2024 07:00AM Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Dec 12, 2023 12:01PM
Dec 12, 2023 12:01PM
Dec 6, 2023 04:02PM
Dec 1, 2023 08:21AM
Dec 1, 2023 08:20AM
Nov 8, 2023 04:01PM
Nov 1, 2023 08:01AM Ligand Pharma (LGND) Acquires Royalty on Sanofi’s (SNY) TZIELD for $20 Million
Nov 1, 2023 08:00AM
Sep 27, 2023 09:02AM
Sep 27, 2023 09:00AM
Sep 26, 2023 05:06PM
Sep 26, 2023 05:05PM
Sep 18, 2023 05:20PM
Sep 18, 2023 05:17PM Ligand Spins Out and Merges Pelican Subsidiary with Primordial Genetics to Form Primrose Bio
Aug 8, 2023 04:01PM

1,158,060 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All